[1]
“Effective prophylaxis of visual and neurological disturbances with an anti-endothelin drug: analysis of 1642 sclerotherapy sessions”, Veins & Lymphatics, vol. 5, no. 1, Dec. 2016, doi: 10.4081/vl.2016.5764.